Here, we showed that although GLS2 reduced the proliferation of GBM cells, it also made them insensitive to the anti-proliferative effects of GLS inhibition by CB-839 (Figure 1C), rendering cells resistant to CB-839 treatment (Figure 1D). Here, GLS2 is linked to glioblastoma.